OBSEVA SA -

OBSEVA SA -

ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. It also is developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a recep... tor antagonist, as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland.

Obseva Sa -_logo

Industry:
Company

Address:
Chemin Des Aulx, 12, Geneva, Switzerland Zipcode 1228

Country:
Switzerland

Phone:
41 22 552 38 40

Market Cap:
206.08M
Total Revenue:
17k
Total Assets:
65.45M
Total Cash:
31.18M

Founder: Ernest Loumaye

Website Url:
http://www.obseva.com


Key Executives
Name Title Pay Year Born
Mr. Brian O'Callaghan Chief Exec. Officer 4,289,000$ 1969(51 years old)
Dr. Ernest Loumaye Co-Founder & Director 1,004,523$ 1952(68 years old)
Mr. David Renas Chief Financial Officer N/A 1964(56 years old)
Dr. Jean-Pierre Gotteland Ph.D. Chief Scientific Officer and Head of R&D N/A 1965(55 years old)
Mr. Fabien Lefebvre de Ladonchamps Chief Admin. Officer N/A 1979(41 years old)
Mr. Mario Vincent Corso Sr. Director of Investor Relations N/A N/A
Ms. Delphine Renaud Personal Assistant to the CSO and Head of R&D N/A N/A
Mr. Wim Souverijns Chief Commercial Officer N/A 1970(50 years old)
Dr. Elizabeth Ijeoma Onyemelukwe Garner Chief Medical Officer N/A 1968(52 years old)



Financial & Stock
Exchange NasdaqGS. Currency in USD. Market state POSTPOST
According to Obseva Sa -'s financial reports the company's revenue in 2020 were 17k an increase( +6.25%) over the years 2019 revenue that were of 16k. In 2020 the company's total earnings were -82.97M while total earnings in 2019 were -108.79M(-24.07%).
Company's stock symbol is OBSV. Lastest price : 2.8100. Total volume :808.16k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.obseva.com

  • Host name: 51.137.92.207
  • IP address: 51.137.92.207
  • Location: Amsterdam Netherlands
  • Latitude: 52.3534
  • Longitude: 4.9087
  • Timezone: Europe/Amsterdam
  • Postal: 1091

Loading ...
Loading ...


More informations about "Obseva Sa -" on Search Engine

Home - ObsEva

Obseva.com Mar 05, 2021 · Welcome to ObsEva. Born in Switzerland in 2012, we’re a clinical-stage biopharmaceutical company with the skills, experience, and backing to usher in a new era in women’s reproductive health. Our purpose is simple, bring to market the products women need. We think of ourselves as the people who nurture your health when nature loses its way.

Home - ObsEva

Obseva.com ObsEva is advancing a pipeline of orally administered, clinical-stage innovative …

Home - ObsEva

Obseva.com ObsEva SA to Participate in JP Morgan Virtual Healthcare Conference January 11 – 14, …

Home - ObsEva

Obseva.com Media Switzerland & Europe. Shauna Dillon +41 (0)22 552 1550 Office +41 79 360 3533 …

Home - ObsEva

Obseva.com Stay on ObsEva.com Continue to link. Disclaimer. Note that the following …

Home - ObsEva

Obseva.com In 2015, ObsEva in-licensed Linzagolix from Kissei Pharmaceutical Co., which had …

Home - ObsEva

Obseva.com ObsEva to Present at the H.C. Wainwright Global Life Sciences Conference. March …

Home - ObsEva

Obseva.com Stay on ObsEva.com Continue to link. Disclaimer. Note that the following …

Home - ObsEva

Obseva.com ObsEva Switzerland Office. Chemin des Aulx,12. 1228, Plan-Les-Ouates, Geneva, …

Home - ObsEva

Obseva.com Company Profile. Founded in November 2012, ObsEva is a clinical-stage …

Home - ObsEva

Obseva.com Nolasiban (OBE001) —Assisted Reproductive Technology. ObsEva is currently advancing …

ObsEva SA (OBSV) Stock Price, News, Quote & History

Finance.yahoo.com ObsEva SA (OBSV) First up is a clinical-state biopharma company with a sharp focus on women’s health. ObsEva is working to develop and commercialize …

Investor confidence shakens after ObsEva SA (NASDAQ:OBSV)

Marketingsentinel.com Apr 14, 2021 · ObsEva SA (NASDAQ:OBSV) has a beta value of 0.77 and has seen 1,271,888 shares traded in the last trading session. The company, currently valued at $208.28 Million, closed the last trade at $2.84 per share which meant it lost -$0.01 on the day or …

ObsEva SA (NASDAQ:OBSV): Making Its Way Up the Stock

Stocksregister.com Apr 10, 2021 · ObsEva SA (NASDAQ:OBSV) shares, dropped in value on Friday, Apr 09, with the stock price down by -2.56% to the previous day’s close as weak demand from buyers trailed the stock to $3.04. Get the hottest stocks to trade every day before the market opens 100% free.

ObsEva SA: New Date Announcement for AGM - Yahoo

Finance.yahoo.com Geneva, Switzerland and Boston, MA – March 27, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to.

ObsEva Provides Update on Yselty® (Linzagolix) Clinical

Globenewswire.com Jan 11, 2021 · GENEVA, Switzerland and BOSTON, MA (Jan 11, 2021) – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s ...

ObsEva SA: ObsEva Provides Business Outlook for 2021

Bloomberg.com Feb 10, 2021 · ObsEva SA: ObsEva Provides Business Outlook for 2021, February 10, 2021, 1:00 AM EST SHARE THIS ARTICLE. Share Tweet Post Email GENEVA, Switzerland and BOSTON, MA (February 10, 2021) – ObsEva SA ...

ObsEva SA (OBSV) Stock Forum & Discussion - Yahoo Finance

Finance.yahoo.com ObsEva SA (OBSV) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Add to watchlist. Visitors trend 2W 10W 9M. 2.8400-0.0100 (-0.35%) At close: …

Short Interest in ObsEva SA (NASDAQ:OBSV) Grows By 84.7%

Theenterpriseleader.com Feb 13, 2021 · ObsEva SA (NASDAQ:OBSV) saw a significant increase in short interest in the month of January. As of January 29th, there was short interest totalling 2,290,000 shares, an increase of 84.7% from the January 14th total of 1,240,000 shares. Approximately 7.3% of the company’s shares are short sold. Based on an average daily trading volume, of […]

Let’s Discuss The ObsEva SA (NASDAQ:OBSV) Stock Forecast

Marketingsentinel.com Mar 15, 2021 · ObsEva SA (OBSV) projections and forecasts. ObsEva SA share prices are not performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen +34.66 percent over the past six months and at a -28.74% annual growth rate that is well below the industry average of ...

OBSV Stock Price | ObsEva S.A. Stock Quote (U.S.: Nasdaq)

Marketwatch.com Apr 09, 2021 · ObsEva S.A. ObsEva SA engages in the research and development of therapeutic treatments for woman's reproductive health and pregnancy. It offers …

Obseva SA (OBSV : NASDAQ) Stock Price & News - Google Finance

Google.com Get the latest Obseva SA (OBSV) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Obseva Sa - OBSV - Stock Price Today - Zacks

Zacks.com Apr 14, 2021 · ObsEva SA is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics for woman's reproductive health and pregnancy. ObsEva SA is ...

ObsEva - Crunchbase Company Profile & Funding

Crunchbase.com ObsEva SA is a Swiss-based, speciality biopharmaceutical company dedicated to the development of innovative drugs for women's reproductive medicine. ObsEva's main focus is on therapies for preterm labor. ObsEva was founded in November 2012, by Ernest Loumaye MD, PhD and André Chollet PhD. Ernest Loumaye is a specialist in female

ObsEva SA | LinkedIn

Linkedin.com Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel...

OBSV: Obseva SA - Stock Price, Quote and News - CNBC

Cnbc.com Obseva SA is a Switzerland-based company active in the pharmaceutical and medical research sector. The Company develops oral compounds to treat women’s reproductive health conditions from ...

ObsEva SA (NASDAQ:OBSV) Shares Could Be 46% Below Their

Finance.yahoo.com How far off is ObsEva SA (NASDAQ:OBSV) from its intrinsic value?Using the most recent financial data, we'll take a look at whether the stock is fairly priced by projecting its future cash flows ...

ObsEva SA. Stock Forecast: up to 3.712 USD! - OBSV Stock

Walletinvestor.com If you are looking for stocks with good return, ObsEva SA. can be a profitable investment option. ObsEva SA. quote is equal to 3.350 USD at 2021-04-03. Based on our forecasts, a long-term increase is expected, the "OBSV" stock price prognosis for 2026-03-27 is 5.522 USD. With a 5-year investment, the revenue is expected to be around +64.84%.

ObsEva SA (OBSV) Latest Stock News & Headlines - Yahoo Finance

Finance.yahoo.com Not to mention substantial upside potential is on the table. ObsEva SA (OBSV) First up is a clinical-state biopharma company with a sharp focus on women’s health. ObsEva is working to develop ...

OBSV:NASDAQ GS Stock Quote - ObsEva SA - Bloomberg Markets

Bloomberg.com ObsEva SA operates as a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of novel therapeutics for …

Should I buy Obseva Sa (OBSV) - Zacks

Zacks.com Apr 09, 2021 · ObsEva SA is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics for woman's reproductive health and pregnancy. ObsEva SA is ...

OBSV Stock Price Increased 61.51%: Why It Happened

Pulse2.com Jan 18, 2021 · The stock price of ObsEva SA (NASDAQ: OBSV) — a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health — has increased by 61.51% on Friday, January 15. There are a few reasons why ObsEva’s stock price has been increasing over the past week. January 11

Analysts suggest ObsEva SA (OBSV) could spike 86.96% in a

Newsrts.com Mar 16, 2021 · ObsEva SA (OBSV) Top Institutional Holders. 68 institutions hold shares in ObsEva SA (OBSV), with 3.19M shares held by insiders accounting for 5.54% while institutional investors hold 51.34% of the company’s shares. The shares outstanding are 55.73M, and float is at 52.82M with Short Float at 4.32%. Institutions hold 48.49% of the Float.

OBSEVA SA : OBSV Stock Price | CH0346177709 | MarketScreener

Marketscreener.com Obseva SA is a Switzerland-based company active in the pharmaceutical and medical research sector. The Company develops oral compounds to treat women’s reproductive health conditions from conception to birth.

Research Analysts Offer Predictions for ObsEva SA's Q1

Marketbeat.com Mar 11, 2021 · ObsEva SA (NASDAQ:OBSV) - Stock analysts at Wedbush lifted their Q1 2021 earnings per share estimates for shares of ObsEva in a research report issued on Monday, March 8th. Wedbush analyst L. Moussatos now forecasts that the company will post earnings per share of …

ObsEva SA (NASDAQ:OBSV) is Worth a Shot if You’re a Risk

Marketingsentinel.com Mar 08, 2021 · ObsEva SA’s EPS for the current quarter is expected to be -$0.37. ObsEva SA (NASDAQ:OBSV) trade information. Although OBSV has turned red as seen at the end of in last trading. With action -4.45%, the performance over the past five days has been red. The jump to weekly highs of $4.05- on Monday, Mar 01 added 20.49% to the stock’s daily price.

Implied Volatility Surging for ObsEva (OBSV) Stock Options

Nasdaq.com Jan 19, 2021 · Investors in ObsEva SA OBSV need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 19, 2021 $2.50 Call had some of the highest implied ...

ObsEva SA (NASDAQ:OBSV): What It’s Worth And What To Do

Marketingsentinel.com Mar 11, 2021 · ObsEva SA (NASDAQ:OBSV)’s traded shares stood at 2,118,109 during the last session, with the company’s beta value hitting 0.86. At the close of trading, the stock’s price was $3.44, to imply a decline of -3.37% or -$0.12 in intraday trading. The OBSV share’s 52-week high remains $6.3 ...

OBSV ObsEva SA Stock Quote - FINVIZ.com

Finviz.com ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual ...

ObsEva SA 6-K Mar. 5, 2021 8:15 AM | Seeking Alpha

Seekingalpha.com Mar 05, 2021 · ObsEva SA, a société anonyme organized under the laws of Switzerland (the “Company”), proposes, subject to the terms and conditions …

Form 6-K ObsEva SA For: Mar 05

Streetinsider.com Requests should be directed to ObsEva SA, Attn: Chief Financial Officer, Chemin des Aulx, 12, 1228 Plan-les-Ouates, Geneva, Switzerland or by telephone at +41 22 552 38 40.

ObsEva SA [OBSV] moved up 11.53: Why It’s Important | The

Dbtnews.com Jan 29, 2021 · ObsEva SA [OBSV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.52. With this latest performance, OBSV shares gained by 85.17% in over the last four-week period, additionally plugging by 47.71% over the last 6 months – not to mention a rise of 1.31% in the past year of trading.

OBSV ObsEva SA stock - Finscreener

Finscreener.org ObsEva SA (NASDAQ: OBSV) stock closed at 3.04 per share at the end of the most recent trading day (a -2.56 % change compared to the prior day closing price) with a volume of 703.47K shares and market capitalization of 174.96M.Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 53 people.

Obseva SA, OBSN:SWX summary - FT.com

Markets.ft.com Obseva SA is a Switzerland-based company active in the pharmaceutical and medical research sector. The Company develops oral compounds to treat women’s reproductive health conditions from conception to …

OBSN:SIX Swiss Ex Stock Quote - ObsEva SA - Bloomberg Markets

Bloomberg.com ObsEva SA operates as a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of novel therapeutics for …

ObsEva SA (Form: 6-K, Received: 07/06/2020 06:32:02)

Content.edgar-online.com Jul 06, 2020 · OBSEVA SA (Translation of registrant’s name into English) Chemin des Aulx, 12 1228 Plan-les-Ouates Geneva, Switzerland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under …

We Analyzed the Future Direction of ObsEva SA (OBSV), Here

Newsheater.com Mar 26, 2021 · ObsEva SA (NASDAQ:OBSV) went up by 5.77% from its latest closing price compared to the recent 1-year high of $6.30. The company’s stock price has collected -2.37% of loss in the last five trading sessions. Press Release reported on 03/05/21 that ObsEva Announces Year End 2020 Financial Results and Business Update. Get the hottest stocks to trade every day before the market opens …

JP Morgan lifts ObsEva SA [OBSV] price estimate. Who else

Dbtnews.com Feb 19, 2021 · ObsEva SA [OBSV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.24. With this latest performance, OBSV shares dropped by -9.77% in over the last four-week period, additionally plugging by 35.96% over the last 6 months – not to mention a rise of 15.07% in the past year of trading.

Jean-Pierre Gotteland, ObsEva SA: Profile and Biography

Bloomberg.com ObsEva SA operates as a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of novel therapeutics for …

OBSV Stock Quote of Obseva Sa - InvestorPlace

Investorplace.com Feb 18, 2021 · Investors in ObsEva SA (OBSV) saw new options begin trading this week, for the November 19th expiration. One of the key data points that goes into the price an option buyer is …

OBSV - Obseva Sa Stock Price - Barchart.com

Barchart.com ObsEva SA is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics for woman's reproductive health and pregnancy. ObsEva SA is headquartered in Geneva, Switzerland.

Buy shares of Obseva SA stock (OBSV) - Stash

Stash.com Obseva SA’s price can fluctuate throughout the course of each trading day—when you buy Obseva SA through Stash, we execute the market order during our next available trading window (we have two a day). At Stash, we don’t recommend trying to predict the market when buying investments.

Obseva Sa Stock Quote: OBSV Stock News, Quotes, Analysis

Research.investors.com obseva sa (obsv) - develops novel therapeutics for serious conditions that compromise a woman's reproductive health.

OBSV - ObsEva Stock Competitors | MarketBeat

Marketbeat.com ObsEva has higher earnings, but lower revenue than Clovis Oncology. ObsEva is trading at a lower price-to-earnings ratio than Clovis Oncology, indicating that it is currently the more affordable of the two stocks. Volatility and Risk. ObsEva has a beta of 0.99, meaning that its stock price is 1% less volatile than the S&P 500.

ObsEva SA Ordinary Shares (OBSV) Stock Price, News & Info

Fool.com ObsEva SA Ordinary Shares (OBSV) Q1 2018 Earnings Conference Call Transcript Motley Fool Staff | May 17, 2018 OBSV earnings call for the period ending March 31, 2018.